In this issue:
Prognostic value of EFS and mortality in follicular lymphoma
Cost-effectiveness of brentuximab vedotin for Hodgkin lymphoma
Haploidentical transplantation for Hodgkin lymphoma
CNS relapse of diffuse large B-cell lymphoma in the rituximab era
Observation as initial management strategy in mantle cell lymphoma
Vosaroxin + decitabine in newly diagnosed older patients with AML or MDS
Factors improving outcomes in paediatric AML successive clinical trials
Post-remission dendritic cell vaccination to prevent or delay relapse in AML
Anti-CD22 immunotoxin moxetumomab pasudotox for childhood ALL
Nilotinib in newly diagnosed CML-CP: final results from ENESTxtnd
Please login below to download this issue (PDF)